Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.
The potential of using artificial intelligence in drug discovery and development has sparked both excitementand skepticism among scientists, investors and the general public. “Artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results